Home › Funds › Commodore Capital LP › DFTX

Commodore Capital LP position in DFTX

DEFINIUM THERAPEUTICS INC · Health Care

Commodore Capital LP reported holding 2,000,000 shares of DFTX (DEFINIUM THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$94.1M, representing 5.60% of its reported portfolio and ranking #6 among its reported holdings. Commodore Capital LP has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)2.00M sh
Reported value held$94.08M
Portfolio Weight5.60%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Commodore Capital LP's DFTX position evolved

Commodore Capital LP first disclosed a stake in DFTX in Q1 2026 at 2,000,000 shares (US$37.8M). The position peaked in Q2 2026 at 2,000,000 shares, worth US$94.1M. Across 2 filings, Commodore Capital LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 2,000,000 shares valued at US$94.1M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 2.00M $37.80M New
Q2 2026 2.00M $94.08M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DFTX and 13F data

DFTX (DEFINIUM THERAPEUTICS INC) is a Health Care company. 189 other funds we track also report a position in DFTX — the largest reported positions include Avoro Capital Advisors LLC (US$338.2M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$322.0M), Octagon Capital Advisors LP (US$138.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DFTX

All DFTX fund holders →

FAQ

How long has Commodore Capital LP held DFTX?

Commodore Capital LP has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Commodore Capital LP's current position in DFTX?

As of Q2 2026, Commodore Capital LP holds 2.00M shares of DFTX (DEFINIUM THERAPEUTICS INC), valued at $94.08M, representing 5.60% of its reported portfolio and ranking #6.

Has Commodore Capital LP been buying or selling DFTX?

In the latest 13F filing (Q2 2026), Commodore Capital LP held unchanged its position in DFTX. The position peaked in Q2 2026 at 2.00M shares.

Which other funds hold DFTX?

Other major institutional holders of DFTX include Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Octagon Capital Advisors LP, among 189 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.